We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summaries from local screening quality assurance (QA) visit reports of abdominal aortic aneurysm (AAA) screening services, including recommendations.
Executive summary of quality assurance (QA) visit to Cambridge University Hospital Foundation Trust held on 4 July 2018.
Update of cardiovascular disease (CVD) data looking at heart disease, diabetes, kidney disease and stroke.
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
Executive summary of quality assurance (QA) visit in Shropshire, Telford and Wrekin held on 21 June 2017.
Executive summary of the quality assurance (QA) visit to the Cheshire and Merseyside NHS abdominal aortic aneurysm screening programme on 30 January 2020.
Executive summary of quality assurance (QA) visit to Derby Teaching Hospitals NHS Foundation Trust held on 17 November 2016.
Evaluation of ultrasound scanners for use in AAA screening in England and Wales.
Executive summary of quality assurance visit to Colchester Hospital University NHS Foundation Trust held on 15 September 2016.
Executive summary of quality assurance (QA) visit to Sussex held on 22 February 2018.
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
A quick reference overview of the NHS abdominal aortic aneurysm (AAA) screening programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).